PMC:7534795 / 114694-115000
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T95 | 25-30 | Body_part | denotes | lipid | http://purl.org/sig/ont/fma/fma67264 |
| T96 | 197-212 | Body_part | denotes | coronary artery | http://purl.org/sig/ont/fma/fma49893 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T156 | 197-212 | Body_part | denotes | coronary artery | http://purl.obolibrary.org/obo/UBERON_0001621 |
| T157 | 206-212 | Body_part | denotes | artery | http://purl.obolibrary.org/obo/UBERON_0001637 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T639 | 163-171 | Disease | denotes | diabetes | http://purl.obolibrary.org/obo/MONDO_0005015 |
| T640 | 173-191 | Disease | denotes | metabolic syndrome | http://purl.obolibrary.org/obo/MONDO_0004955 |
| T641 | 197-220 | Disease | denotes | coronary artery disease | http://purl.obolibrary.org/obo/MONDO_0005010 |
| T642 | 206-220 | Disease | denotes | artery disease | http://purl.obolibrary.org/obo/MONDO_0000473 |
| T643 | 267-275 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T156 | 206-212 | http://purl.obolibrary.org/obo/UBERON_0001637 | denotes | artery |
| T157 | 206-212 | http://www.ebi.ac.uk/efo/EFO_0000814 | denotes | artery |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T59078 | 7-14 | Chemical | denotes | statins | http://purl.obolibrary.org/obo/CHEBI_87631 |
| T14528 | 25-30 | Chemical | denotes | lipid | http://purl.obolibrary.org/obo/CHEBI_18059 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T702 | 0-306 | Sentence | denotes | Use of statins and other lipid-modulating therapies can reduce the risk of primary or secondary cardiovascular events in at-risk individuals, including those with diabetes, metabolic syndrome, and coronary artery disease – conditions that are risk factors for severe COVID-19 outcomes (Stone et al., 2013). |
2_test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 33031856-24239923-84039157 | 300-304 | 24239923 | denotes | 2013 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 3310 | 25-30 | Chemical | denotes | lipid | MESH:D008055 |
| 3316 | 163-171 | Disease | denotes | diabetes | MESH:D003920 |
| 3317 | 173-191 | Disease | denotes | metabolic syndrome | MESH:D024821 |
| 3318 | 197-220 | Disease | denotes | coronary artery disease | MESH:D003324 |
| 3319 | 267-275 | Disease | denotes | COVID-19 | MESH:C000657245 |